
Things are going so well for the allergy company ALK that the firm told the market Thursday morning that it was raising its full-year earnings guidance.
Whereas the company used to expect an operational result (earnings before interest, taxes, depreciations, amortizations, -ed.) at DKK 300-350m (USD 47.8m-55.8m), ALK now guides for DKK 350-400m.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app